Publications by authors named "M A Arevalo"

Introduction: Axial spondyloarthritis (axSpA) is a chronic inflammatory condition associated with considerable pain and impaired health-related quality of life (HRQoL) for affected patients. Despite the documented increase in healthcare resource utilization (HRU) related to axSpA, few studies have explored the impact of diagnostic delays on these outcomes. This study sought to determine the association between diagnostic delay of axial spondyloarthritis (axSpA) and costs in the 3 years after diagnosis.

View Article and Find Full Text PDF

Background: Inflammatory bowel disease (IBD) affects 5%-10% of ankylosing spondylitis (AS) patients. Prior data suggest AS patients with IBD may have more severe disease and lower HLA-B27 prevalence. Yet, little is known about potential distinctions in AS with IBD compared to those without IBD.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on cross-border health service utilization at the Mexico-Guatemala border, highlighting the less-researched movement between low- and middle-income countries.
  • It employed a mixed-methods approach, conducting a survey of 4,733 border crossers and 28 interviews to assess the frequency and reasons for seeking health care and medicines across the border.
  • Findings revealed that 3.8% sought health care, with affordability and perceived quality being key drivers, while the use of public services primarily targeted preventive care, benefiting both local economies and health promotion.
View Article and Find Full Text PDF
Article Synopsis
  • Killian-Jamieson diverticulum (KJD) is a rare esophageal condition typically treated with surgery, but a new method called KJ-POEM (per-oral endoscopic myotomy) offers a minimally invasive alternative.
  • An international study reviewing 13 patients who underwent KJ-POEM found that both clinical and technical success rates were 100%, with significant symptom improvement post-procedure.
  • The procedure demonstrated excellent safety, with no adverse events reported, a short hospital stay of about 1 day, and no recurrence of symptoms during the follow-up period of nearly 9.5 months.
View Article and Find Full Text PDF

Background And Objective: Oral ivermectin, a broad-spectrum anti-parasitic drug, alone or in combination with permethrin, may be a cheaper and more convenient alternative drug to topical permethrin alone in the treatment of classic scabies. There are no previous studies on the treatment acceptability of the three interventions among individual patients with scabies in the Philippines.The purpose of this study was to understand the experiences and perceptions on treatment acceptability for oral ivermectin, topical permethrin or combination treatment among patients with scabies using the multiple-case study approach.

View Article and Find Full Text PDF